Rotavirus epidemiology and surveillance in Argentina: 2009-2011;Vigilancia epidemiológica de rotavirus en la Argentina: 2009-2011

Archivos Argentinos de Pediatria

Volumn 111, Issue 2, 2013, Pages 148-154

  Degiuseppe, Juan Ignacio ^a   Giovacchini, Carlos ^b   Stupka, Juan Andrés ^a   Amarilla, Alejandra ^c   Ayala, Carmen ^d   Beltramino, Juan ^e   Bulgheroni, María Fernanda ^c   Cabral, María José ^f   Caillou, Ernesto ^g   Camacho, Norma ^h   Canna, Fernando ⁱ   Correa, Silvia ^j   Di Prátula, Darío ^k   Espejo, Rogelio ^l   Ferrari, Ana ^l   Fierro, Leopoldo ^l   Grucci, Sandra ^m   Larini, Silvia ⁿ   Lozano, Elena ^o   Lucero, Noelia ^p   Labarthe, Carlos Pérez ^q   Roldán, Carlos ^r   Silveyra, Ivana ^r   Vera, Alejandra ^s   more..

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b Ministerio de Salud de la Nación ^*  (Argentina)

^c Htal Heller   (Argentina)

^d Htal Perón   (Argentina)

^e Htal Alassia   (Argentina)

^f Htal Eva Perón   (Argentina)

^g Htal del Niño Jesús   (Argentina)

^h Htal Castellanos   (Argentina)

ⁱ Laboratorio Central   (Argentina)

^j Hospital San Luis   (Argentina)

^k Htal Zatti   (Argentina)

^l Htal Rawson   (Argentina)

^m Htal Notti   (Argentina)

ⁿ Htal Vilela   (Argentina)

^o Htal Quintana   (Argentina)

^p Htal Schestakow   (Argentina)

^q Hospital La Madre y el Niño   (Argentina)

^r Htal Garrahan CABA ^*  (Argentina)

^s Hospital Regional Río Gallegos   (Argentina)

more..

Author keywords

Argentina; Diarrhea; Epidemiological surveillance; Rotavirus

Indexed keywords

ACUTE DIARRHEA; ARGENTINA; ARTICLE; DISEASE SURVEILLANCE; GENOTYPE; GROUPS BY AGE; HOSPITAL ADMISSION; HUMAN; PREVALENCE; ROTAVIRUS; SEASONAL VARIATION;

ADOLESCENT; ADULT; AGED; ARGENTINA; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; HUMANS; INFANT; MIDDLE AGED; PREVALENCE; ROTAVIRUS INFECTIONS; TIME FACTORS; YOUNG ADULT;

EID: 84878865000     PISSN: 03250075     EISSN: 16683501     Source Type: Journal    
DOI: 10.5546/aap.2013.148     Document Type: Article

References (31)

1. Organización Mundial de la Salud. Centro de prensa. Enfermedades diarreicas. 2009; nota descriptiva no 330. [Acceso: 4 de junio de 2012]. Disponible en: http://www.who.int/mediacentre/factsheets/fs330/es/
2. Ministerio de Salud de la Nación. Boletín Epidemiológico Anual 2010. Argentina, 2011. [Acceso: 4 de junio de 2012]. Disponible en http://msal.gov.ar/htm/site/sala-situacion/PANELES/bep-anual- 2010/BEPANUAL-2010.pdf.
3. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infec Dis 2009;200(Suppl 1):S9-S15.
4. OPS/Sabin Institute. Simposio Regional de Nuevas Vacunas. Perú, 2009. [Acceso: 12 de junio de 2012]. Disponible en: http://www.sabin.org/files/ attachment/Simposio%20Regional%20de%20Nuevas%20Vacunas.pdf.
5. Gómez JA, Sordo ME, Gentile A. Epidemiologic patterns of diarrheal disease in Argentina: estimation of rotavirus disease burden. Pediatr Infect Dis J 2002;21(9):843-50.
6. World Health Organization. Rotavirus vaccines: an update. Weekly Epidemiolog Record 2009;84(50):533-40.
7. Dirección de Estadísticas e Información en Salud. Indicadores básicos 2011. Argentina, 2012. [Acceso: 4 de junio de 2012]. Disponible en http://www.deis.gov.ar/publicaciones/archivos/indicadores-2011. pdf.
8. Ministerio de Salud de la Nación. SIVILA. Argentina, 2011. [Acceso: 6 de junio de 2012]. Disponible en http://www.msal.gov.ar/index.php/ home/funciones/area-devigilancia/sivila
9. Department of Immunization, Vaccines and Biologicals (WHO). Manual of rotavirus detection and characterization methods. Switzerland, 2009;1-9.
10. Gouvea V, Glass RI, Woods P, Taniguchi K, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990;28(2):276-82.
11. Das BK, Gentsch JR, Cicirello HG, Woods PA, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol 1994;32(7):1820-2.
12. Gentsch JR, Glass RI, Woods P, Gouvea V, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992;30(6):1365-73.
13. Bok K, Castagnaro N, Borsa A, Nates S, et al. Surveillance for rotavirus in Argentina. J Med Virol 2001;65(1):190-8.
14. Velázquez FR, Garcia-Lozano H, Rodriguez E, Cervantes Y, et al. Diarrhea morbidity and mortality in Mexican children: impact of rotavirus disease. Pediatr Infect Dis J 2004;23(10 Suppl):S149-55.
15. World Health Organization. Rotavirus vaccines. Weekly Epidemiological Record 2007;82(32):285-95.
16. Lanzieri TM, Costa I, Shafi FA, Cunha MH, et al. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr Infect Dis J 2010;29(7):673-5.
17. de Palma O, Cruz L, Ramos H, de Baires A, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010;340:c2825.
18. Patel M, Pedreira C, De Oliveira LH, Tate J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009;301(21):2243-51.
19. Molto Y, Cortes JE, De Oliveira LH, Mike A, et al. Reduction of diarrhea-associated hospitalizations among children aged < 5 Years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 2011;30(1 Suppl):S16-20.
20. Boom JA, Tate JE, Sahni LC, Rench MA, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010;125(2):e199-207.
21. Buttery JP, Lambert SB, Grimwood K, Nissen MD, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011;30(1 Suppl):S25-9.
22. Curns AT, Steiner CA, Barrett M, Hunter K, et al. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010;201(11):1617-24.
23. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354 (1):11-22.
24. Vesikari T, Karvonen A, Prymula R, Schuster V, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007;370(9601):1757-63.
25. Ciarlet M, Schodel F. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, Rota Teq. Vaccine 2009;27(Suppl 6):G72-81.
26. Vesikari T, Karvonen A, Ferrante SA, Kuter BJ, et al. Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine. Pediatr Infect Dis J 2010;29(10):957-63.
27. Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J 2011;30(1 Suppl):S48-53.
28. Hull JJ, Teel EN, Kerin TK, Freeman MM, et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011;30(1 Suppl):S42-7.
29. Stupka JA, Carvalho P, Amarilla AA, Massana M, et al. National rotavirus surveillance in Argentina: high incidence of G9P[8] strains and detection of G4P[6] strains with porcine characteristics. Infect Genet Evol 2009;9(6):1225-31.
30. Stupka JA, Degiuseppe JI, Parra GI. Increased frequency of rotavirus G3P[8] and G12P[8] in Argentina during 2008-2009: whole-genome characterization of emerging G12P[8] strains. J Clin Virol 2012;54(2):162-7.
31. Gurgel RQ, Cuevas LE, Vieira SC, Barros VC, et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 2007;13(10):1571-3.